SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000850261-18-000033
Filing Date
2018-11-09
Accepted
2018-11-09 17:07:21
Documents
116
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q srne9301810-q.htm 10-Q 1448102
2 EXHIBIT 4.1 exhibit41.htm EX-4.1 122581
3 EXHIBIT 4.2 exhibit42.htm EX-4.2 188215
4 EXHIBIT 10.1 exhibit101.htm EX-10.1 836997
5 EXHIBIT 10.2 exhibit102.htm EX-10.2 261231
6 EXHIBIT 10.3 exhibit103.htm EX-10.3 276268
7 EXHIBIT 10.4 exhibit104.htm EX-10.4 49248
8 EXHIBIT 10.5 exhibit105.htm EX-10.5 843049
9 EXHIBIT 10.6 exhibit106.htm EX-10.6 37692
10 EXHIBIT 31.1 exhibit311.htm EX-31.1 12182
11 EXHIBIT 31.2 exhibit312.htm EX-31.2 11996
12 EXHIBIT 32.1 exhibit321.htm EX-32.1 13309
  Complete submission text file 0000850261-18-000033.txt   13380058

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE DOCUMENT srne-20180930.xml EX-101.INS 1865222
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srne-20180930.xsd EX-101.SCH 98719
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srne-20180930_cal.xml EX-101.CAL 113874
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srne-20180930_def.xml EX-101.DEF 790068
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srne-20180930_lab.xml EX-101.LAB 1131851
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srne-20180930_pre.xml EX-101.PRE 913960
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 181173915
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9